113 related articles for article (PubMed ID: 8625335)
1. Palliative treatment for advanced gastrointestinal cancer: is response a suitable end-point?
Jäger E; Bernard H; Knuth A
Cancer Treat Rev; 1996 Jan; 22 Suppl A():113-5. PubMed ID: 8625335
[No Abstract] [Full Text] [Related]
2. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
[No Abstract] [Full Text] [Related]
3. Combination of carmofur and interferon-alpha-2B in advanced gastrointestinal cancer--a phase II pilot study.
Gröhn P; Helle L; Numminen S; Heinonen E
Acta Oncol; 1994; 33(6):711-3. PubMed ID: 7946457
[No Abstract] [Full Text] [Related]
4. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.
Moore MJ; Erlichman C; Kaizer L; Fine S
Anticancer Drugs; 1993 Oct; 4(5):555-7. PubMed ID: 8292812
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic study of 5-FU/leucovorin and alpha-interferon in advanced cancer.
Larsson PA; Glimelius B; Jeppsson B; Jönsson PE; Malmberg M; Gustavsson B; Carlsson G; Svedberg M
Acta Oncol; 2000; 39(1):59-63. PubMed ID: 10752655
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
Shapiro JD; Harold N; Takimoto C; Hamilton JM; Vaughn D; Chen A; Steinberg SM; Liewehr D; Allegra C; Monahan B; Lash A; Grollman F; Flemming D; Behan K; Johnston PG; Haller D; Quinn M; Morrison G; Grem JL
Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
[TBL] [Abstract][Full Text] [Related]
8. Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
Cascinu S; Alessandroni P; Rossi D; Del Ferro E; Fedeli A; Casadei V; Catalano G
Cancer Chemother Pharmacol; 1996; 38(4):385-6. PubMed ID: 8674163
[TBL] [Abstract][Full Text] [Related]
9. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy.
Pratt CB; Rao BN; Merchant TE; Shah A; Avery L; Cain A; Bodner S; Poquette C; Tan M
Med Pediatr Oncol; 1999 Jun; 32(6):459-60. PubMed ID: 10358711
[No Abstract] [Full Text] [Related]
10. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
[TBL] [Abstract][Full Text] [Related]
11. The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
Nichols PH; Ward U; Ramsden CW; Primrose JN
Br J Cancer; 1994 Nov; 70(5):946-9. PubMed ID: 7947102
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines as immunotherapy in cancer].
Sinnige HA; Mulder NH
Ned Tijdschr Geneeskd; 1992 May; 136(21):1033-4. PubMed ID: 1603153
[No Abstract] [Full Text] [Related]
13. Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours.
Papamichael D; Seymour MT; Penson RT; Wilson P; Gallagher CJ; Besser GM; Slevin ML
Eur J Cancer; 1998 Dec; 34(13):2133-4. PubMed ID: 10070325
[No Abstract] [Full Text] [Related]
14. A phase I study of escalating interferon alpha-2a combined with 5-fluorouracil and leucovorin in patients with gastrointestinal malignancies.
Trudeau M; Zukiwski A; Langleben A; Boos G; Hayden K; Batist G
Acta Oncol; 1993; 32(5):537-9. PubMed ID: 8217238
[TBL] [Abstract][Full Text] [Related]
15. Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy.
Bruckner HW; Spigelman M
Mt Sinai J Med; 1988 Oct; 55(5):390-4. PubMed ID: 3265179
[No Abstract] [Full Text] [Related]
16. [Efficacy of intra-arterial high-dose leucovorin and 5-FU including combination chemotherapy].
Mitsuhata N; Matsuda T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3287-90. PubMed ID: 3490831
[No Abstract] [Full Text] [Related]
17. Treatment of gastrointestinal and renal adenocarcinomas with interferon-alpha.
Meadows LM; Lindley C; Ozer H
Biotherapy; 1992; 4(3):179-87. PubMed ID: 1599801
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
Seymour MT; Slevin ML; Kerr DJ; Cunningham D; James RD; Ledermann JA; Perren TJ; McAdam WA; Harper PG; Neoptolemos JP; Nicholson M; Duffy AM; Stephens RJ; Stenning SP; Taylor I
J Clin Oncol; 1996 Aug; 14(8):2280-8. PubMed ID: 8708718
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic strategies for patients with gastrointestinal malignancies using biochemical modulation of fluorouracil.
Allegra CJ
JAMA; 1995 Jan; 273(3):236-9. PubMed ID: 7807664
[No Abstract] [Full Text] [Related]
20. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
